Moderna Impact Investors
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
%20Ltd.jpeg)
Investors
.png)
Funding Status:
IPO
Industry:
Innovation, Technology, and Research
Estimated Revenue:
$100M to $500M
Technology:
COVID
Acquisitions Number:
Made Acquisitions
Number Of Exists:
N/A
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
2981600000.0
Last Funding Date:
2022-10-12
Last Funding Type:
Post-IPO Equity
Investor Type:
Investment Bank
Employee Number:
N/A
Investors Number:
4
Investment Stage:
N/A
Founded Date:
2010-01-01